BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 19815826)

  • 1. Cardiac metabolic state and Brugada syndrome: a link revealed.
    Chahine M
    Circ Res; 2009 Oct; 105(8):721-3. PubMed ID: 19815826
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac Na+ current regulation by pyridine nucleotides.
    Liu M; Sanyal S; Gao G; Gurung IS; Zhu X; Gaconnet G; Kerchner LJ; Shang LL; Huang CL; Grace A; London B; Dudley SC
    Circ Res; 2009 Oct; 105(8):737-45. PubMed ID: 19745168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPD1L links redox state to cardiac excitability by PKC-dependent phosphorylation of the sodium channel SCN5A.
    Valdivia CR; Ueda K; Ackerman MJ; Makielski JC
    Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1446-52. PubMed ID: 19666841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive oxygen species originating from mitochondria regulate the cardiac sodium channel.
    Liu M; Liu H; Dudley SC
    Circ Res; 2010 Oct; 107(8):967-74. PubMed ID: 20724705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias.
    London B; Michalec M; Mehdi H; Zhu X; Kerchner L; Sanyal S; Viswanathan PC; Pfahnl AE; Shang LL; Madhusudanan M; Baty CJ; Lagana S; Aleong R; Gutmann R; Ackerman MJ; McNamara DM; Weiss R; Dudley SC
    Circulation; 2007 Nov; 116(20):2260-8. PubMed ID: 17967977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Just another Brugada syndrome mutation?
    Napolitano C
    Heart Rhythm; 2007 Jan; 4(1):54-5. PubMed ID: 17198990
    [No Abstract]   [Full Text] [Related]  

  • 7. The complexity of genotype-phenotype relations associated with loss-of-function sodium channel mutations and the role of in silico studies.
    Wilde AA; Coronel R
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H8-9. PubMed ID: 18502906
    [No Abstract]   [Full Text] [Related]  

  • 8. Absence of a trafficking defect in R1232W/T1620M, a double SCN5A mutant responsible for Brugada syndrome.
    Makita N; Mochizuki N; Tsutsui H
    Circ J; 2008 Jun; 72(6):1018-9. PubMed ID: 18503232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compound heterozygous SCN5A mutations: does the sum of the parts equal the whole?
    Benson DW
    Heart Rhythm; 2009 Aug; 6(8):1176-7. PubMed ID: 19560406
    [No Abstract]   [Full Text] [Related]  

  • 10. Ca2+/calmodulin-dependent protein kinase II (CaMKII) regulates cardiac sodium channel NaV1.5 gating by multiple phosphorylation sites.
    Ashpole NM; Herren AW; Ginsburg KS; Brogan JD; Johnson DE; Cummins TR; Bers DM; Hudmon A
    J Biol Chem; 2012 Jun; 287(24):19856-69. PubMed ID: 22514276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A sodium channel pore mutation causing Brugada syndrome.
    Pfahnl AE; Viswanathan PC; Weiss R; Shang LL; Sanyal S; Shusterman V; Kornblit C; London B; Dudley SC
    Heart Rhythm; 2007 Jan; 4(1):46-53. PubMed ID: 17198989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical marker for Na+ CP type Valpha (C-20) and heterozygous nonsense SCN5A mutation W822X in a sudden cardiac death induced by mild anaphylactic reaction.
    Turillazzi E; Pomara C; La Rocca G; Neri M; Riezzo I; Karch SB; Anzalone R; Lo Iacono M; Fineschi V
    Appl Immunohistochem Mol Morphol; 2009 Jul; 17(4):357-62. PubMed ID: 19318916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analyses of a novel SCN5A mutation (C1850S): conduction vs. repolarization disorder hypotheses in the Brugada syndrome.
    Petitprez S; Jespersen T; Pruvot E; Keller DI; Corbaz C; Schläpfer J; Abriel H; Kucera JP
    Cardiovasc Res; 2008 Jun; 78(3):494-504. PubMed ID: 18252757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic basis of Brugada syndrome.
    Antzelevitch C
    Heart Rhythm; 2007 Jun; 4(6):756-7. PubMed ID: 17556198
    [No Abstract]   [Full Text] [Related]  

  • 15. Ventricular tachycardia in a Brugada syndrome patient caused by a novel deletion in SCN5A.
    Tfelt-Hansen J; Jespersen T; Hofman-Bang J; Rasmussen HB; Cedergreen P; Skovby F; Abriel H; Svendsen JH; Olesen SP; Christiansen M; Haunso S
    Can J Cardiol; 2009 Mar; 25(3):156-60. PubMed ID: 19279983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SCN5A gene in Brugada syndrome: mutations, variants, missense and nonsense. What's a clinician to do?
    Skinner JR; Love DR
    Heart Rhythm; 2010 Jan; 7(1):50-1. PubMed ID: 20129285
    [No Abstract]   [Full Text] [Related]  

  • 17. Compound heterozygous mutations P336L and I1660V in the human cardiac sodium channel associated with the Brugada syndrome.
    Cordeiro JM; Barajas-Martinez H; Hong K; Burashnikov E; Pfeiffer R; Orsino AM; Wu YS; Hu D; Brugada J; Brugada P; Antzelevitch C; Dumaine R; Brugada R
    Circulation; 2006 Nov; 114(19):2026-33. PubMed ID: 17075016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium channel kinetic changes that produce Brugada syndrome or progressive cardiac conduction system disease.
    Zhang ZS; Tranquillo J; Neplioueva V; Bursac N; Grant AO
    Am J Physiol Heart Circ Physiol; 2007 Jan; 292(1):H399-407. PubMed ID: 16877553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brugada syndrome: lots of questions, some answers.
    Roden DM
    Heart Rhythm; 2010 Jan; 7(1):47-9. PubMed ID: 20129284
    [No Abstract]   [Full Text] [Related]  

  • 20. Elevated oxidative stress is associated with ventricular fibrillation episodes in patients with Brugada-type electrocardiogram without SCN5A mutation.
    Tanaka M; Nakamura K; Kusano KF; Morita H; Ohta-Ogo K; Miura D; Miura A; Nakagawa K; Tada T; Murakami M; Nishii N; Nagase S; Hata Y; Kohno K; Ouchida M; Shimizu K; Yutani C; Ohe T; Ito H
    Cardiovasc Pathol; 2011; 20(1):e37-42. PubMed ID: 20219395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.